In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg
Several disease-associated mutant proteins are subject to regulation via both ERAD and ER-phagy, including Akita proinsulin in diabetes, 248,265,274,275 POMC C28F in early-onset obesity, proAVP G57S in diabetes insipidus, 276,277 and NPC1 I1061T in NiemannPick type C disease
Lisa S I lost 30 lbs nine years ago with Dr Pinto, meet with Julie Heckman once a I lost 30 lbs nine years ago with Dr Pinto, meet with Julie Heckman once a month, and keep the weight off
Yes, for most people, this is a safe and potentially effective way to support intensive wellness goals